In this segment from Tuesday's Investor Beat, Motley Fool analyst Morgan Housel discusses the iShares NASDAQ Biotechnology Index (NASDAQ:IBB), and why he sees many tell-tale red flags that the biotech space is in a bubble right now. Morgan gives his insight on what these warning signs are, and whether or not the bubble could be near collapse.

Chris Hill has no position in any stocks mentioned. Morgan Housel has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.